This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Richard Suttmeier

Expert Contributor

Richard Suttmeier, a former U.S. Treasury trader and trading manager in the primary dealer community, has more than 40 years of experience in the U.S. financial markets. Richard is an engineer by education with a master of science degree. He has been writing newsletters and market commentaries since 1984, and his engineering and trading background are the foundation for the combined fundamental and technical analysis used in the stories he writes exclusively for TheStreet.com. Richard’s “Crunching the Numbers” tables provide; key moving averages, weekly stochastic readings, earnings estimates, and value levels and risky levels at which to buy on weakness or to sell on strength. His stories cover: regional and community banks including data from the FDIC Quarterly Banking Profile, homebuilders following NAHB data and single-family starts, and stocks in several sectors including, transportation, healthcare, and retail. During earnings season Richard provides trading guidelines for popular stocks before they report, then scorecards after they report.


Facebook: Financial Market Strategist
Google: Richard Suttmeier

Richard Suttmeier
By This Author:
« Back
Page 1 of 263

Conagra, Cracker Barrel, Herman Miller, Pier 1, Rite Aid Report Earnings

By Richard Suttmeier

Conagra, Cracker Barrel, Herman Miller, Pier 1, Rite Aid to report earnings.

01:11PM 09/16/14

Hewlett-Packard’s Must-See Charts Show Vulnerability for the Shares

By Richard Suttmeier

This technical analysis for Hewlett-Packard looks at daily and weekly charts and provides value levels at which to buy and risky levels at which to sell.

02:50PM 09/12/14

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

By Richard Suttmeier

Here are some numbers to help investors make prudent decisions when allocating cash to 11 big-cap pharmaceutical companies.

11:32AM 09/12/14

Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs

By Richard Suttmeier

Here are some numbers that may help you navigate the volatile and expensive biotech sector.

10:02AM 09/11/14

Margin of Safety: 10 Utility, Dividend Stocks to Consider

By Richard Suttmeier

These stocks offer healthy dividends as well as some safety in what could be a down market.

10:06AM 09/10/14

Aetna, Centene, HealthNet, Humana, WellPoint Surge on Obamacare

By Richard Suttmeier

Dow component UnitedHealth also gains on the Affordable Care Act, but CNO Financial and WellCare fell short of earnings estimates and pulled back.

11:35AM 09/09/14

Four Momentum Stocks That Have Outperformed Apple

By Richard Suttmeier

The iPhone 6 will make its debut Tuesday. But as for Apple's stock, Amazon, Google, Netflix and Tesla have done better during the past four weeks.

09:58AM 09/09/14

Darden, Kroger, Lululemon, Ulta Salon: How to Trade Their Earnings

By Richard Suttmeier

Seven retail-oriented companies report quarterly results this week. They also include Barnes & Noble, Pep Boys and Vera Bradley.

01:39PM 09/08/14

« Back
Page 1 of 263

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs